English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Nyu Langone

+ Regulatory
Patient Daily Report | May 18, 2023

NYU Langone Health professor: 'This study is the first collaboration of this focus and scale to find that adults with sleep apnea are at greater risk for long COVID'

+ Community
Press release submission | Jan 27, 2022

New Study Validates Benefits of Convalescent Plasma for Some COVID-19 Patients

+ Technology/Innovation
Press release submission | Jan 12, 2019

NYU LANGONE: New Analytic Model to Better Identify Patients Likely to Develop PTSD

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily